가시오갈피 잎에 함유된 α-glucosidase의 저해 활성 물질의 분리를 위하여 가시오갈피 잎 80% 에탄올 추출물을 극성유기 용매를 사용하여 순차 분획하고 각 분획층을 α-glucosidase의 저해 활성 효과를 측정한 결과, EtOAc 층이 68.05%로 가장 높은 저해 활성을 나타내었다. EtAOc 분획층을 MPLC를 이용하여 fractionation-directed isolation을 수행하고 최종적으로 α-glucosidase 저해 활성이 93.60%로 가장 우수하게 나타난 EAHC 분획물을 얻었다. EAHC 분획물을 prep-LC/MS로 분석하여 EAHCA와 EAHCB로 분리ㆍ정제하였다. EAHCA 분획물의 화학구조를 구명하기 위하여 ¹H-NMR, <SUP>13</SUP>C-NMR로 분석한 결과, 분자량 464.38 g/㏖, 화학구조식 C<SUB>21</SUB>H<SUB>20</SUB>O<SUB>12</SUB>인 hyperoside로 확인되었다. EAHCB 분획물의 화학구조를 구명하기 위하여 1H-NMR, <SUP>13</SUP>C-NMR로 분석한 결과, 분자량 464.38 g/㏖, 화학구조식 C<SUB>21</SUB>H<SUB>20</SUB>O<SUB>12</SUB>인 isoquercetin으로 확인되었다. 본 연구 결과, 가시오갈피 잎으로부터 분리ㆍ동정된 hyperoside와 isoquercetin은 α-glucosidase의 저해 활성 물질을 가진 화합물로 향후 혈당조절용 건강식품 또는 치료제 개발을 위한 물질로 활용될 수 있을 것으로 판단된다.
In the present investigation, the anti-diabetic potential of 80% ethanol extract of Eleutherococcus senticosus leaves (EEES) was examined based on α-glucosidase inhibitory activities. EEES was sequentially fractionated with n-hexane, chloroform, ethyl acetate (EtAOc), n-butanol, and H₂O. Of the various fractions, EtAOc fraction effectively inhibited α-glucosidase activity by 68.05%. Therefore, EtAOc fraction was selected for further isolation and identification studies. EtAOc fraction was separated by medium pressure liquid chromatography with silica and ODS gel to yield eight fractions (EAA~EAH). Based on the results of α-glucosidase inhibitory activity, EAH fraction was re-chromatographed to yielded four more fractions (EAHA~EAHD). Of these, EAHC fraction showed higher α-glucosidase inhibitory activity of 93.60%. EAHC fraction was re-chromatographed and yielded EAHCA and EAHCB fractions. Further, identification and chemical structures of these two fractions were analyzed using ¹H-NMR, <SUP>13</SUP>C-NMR, and mass spectra data. Based on the results of the spectral data, the isolated compounds were identified as hyperoside and isoquercetin. Results of the present study indicate that the isolated compounds, hyperoside, and isoquercetin from leaves of E. senticosus could be used for the development of new anti-diabetic drugs.